title: Severe ocular irritation and corneal deposits associated with capecitabine use.
authors.forename: B
authors.initials: B
authors.lastname: Waikhom
authors.forename: F T
authors.initials: FT
authors.lastname: Fraunfelder
authors.forename: W D
authors.initials: WD
authors.lastname: Henner
authors.forename: B
authors.initials: B
authors.lastname: Walkhom
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000556:secondary; D000069287:Capecitabine; D003316:Corneal Diseases / Q000139:chemically induced*; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D007634:Keratitis / Q000139:chemically induced; D007638:Keratoconjunctivitis Sicca / Q000150:complications; D008875:Middle Aged; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil